Skip to main content
. 2024 Mar 1;116(1):32–45. doi: 10.32074/1591-951X-926

Figure 2.

Figure 2.

Kits, platforms, and turnaround time(TAT) for MMRd testing in IHC. (A) Laboratories kit adoption (based on manufacturers) for MLH1, MSH2, MSH6, PMS2 by countries for the assessment of MMRd. N: total number of laboratories from the different countries.(B) Platforms used by the different laboratories in Italy, Spain, Switzerland, UK for the assessment of MMRd by IHC. N: total number of laboratories from the different countries.(C) TAT for MMd testing by country: average of time in days from when the sample is received by the laboratories to the final report of the result. N: total number of laboratories from the different countries.